0
0
12/13/23 at 12:04pm
Organization
Drug Target Review
28 words
0
Comments
NETs require epidermal growth factor to grow, meaning that inhibiting EGF receptors could treat these types of tumours.
You are the first to view
https://www.drugtargetreview.com/news/113144/new-organoid-model-of-neuroendocrine-tumours-developed/
Create an account
or login to join the discussion